Sangamo Therapeutics
SGMO
SGMO
217 hedge funds and large institutions have $1.1B invested in Sangamo Therapeutics in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 74 increasing their positions, 57 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
217
Holders Change
+7
Holders Change %
+3.33%
% of All Funds
4.97%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
35
Increased
74
Reduced
57
Closed
28
Calls
$36.1M
Puts
$36M
Net Calls
+$97K
Net Calls Change
+$2.61M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$17.2M |
| 2 |
Goldman Sachs
New York
|
+$10.2M |
| 3 |
CC
Casdin Capital
New York
|
+$10.2M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$8.24M |
| 5 |
Millennium Management
New York
|
+$7.59M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$31.4M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$19.8M |
| 3 |
NC
Nexthera Capital
New York
|
-$15.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.2M |
